CorrectSequence base editing keeps sickle cell patient crisis-free for 18 months
CorrectSequence’s transformer base-editing platform produced sustained fetal hemoglobin above 60% and freedom from vaso-occlusive crises in a Nigerian sickle cell patient, while three additional thalassemia patients became transfusion independent.